Trial Watch

Clinical trials covered by The Clinical Lighthouse, ranked by methodological rigor and ordered by most recent.

213 trials indexed
Prehospital Whole Blood Does Not Reduce 30-Day Mortality Over Components
PIVOTAL TRIAL · LAST 30 DAYS
Randomized Controlled Trial New England Journal of Medicine

Prehospital Whole Blood Does Not Reduce 30-Day Mortality Over Components

A large-scale trial found no significant difference in 30-day mortality between prehospital whole blood and component transfusions for trauma.

May 20, 2026 Read the trial →
Tucidinostat Improves Event-Free Survival in Double-Expressor B-Cell Lymphoma Randomized Controlled Trial
JAMA

Tucidinostat Improves Event-Free Survival in Double-Expressor B-Cell Lymphoma

Adding a histone deacetylase inhibitor to R-CHOP increases complete response rates and reduces progression risk in high-risk patients.

April 24, 2026
Dialectical Behavior Therapy and Schema Therapy Show Similar Efficacy for BPD Randomized Controlled Trial
JAMA Psychiatry

Dialectical Behavior Therapy and Schema Therapy Show Similar Efficacy for BPD

A 3-year randomized trial found no significant difference in symptom reduction or dropout between these two intensive psychotherapies.

April 24, 2026
Tranexamic Acid Reduces Major Bleeding in Urologic Surgery Randomized Controlled Trial
European Urology

Tranexamic Acid Reduces Major Bleeding in Urologic Surgery

A randomized trial of 1,124 patients shows TXA reduces major bleeding by 3.4% without significantly increasing 30-day thrombotic risk.

April 23, 2026
Behavioral Nursing Model Improves Glycemic Control and Cognition in Older Diabetes Patients Randomized Controlled Trial
Frontiers in Psychiatry

Behavioral Nursing Model Improves Glycemic Control and Cognition in Older Diabetes Patients

A three-month Information-Motivation-Behavioral Skills intervention reduced HbA1c and psychological distress while improving cognitive scores.

April 23, 2026
Estradiol Patches Noninferior to LHRH Agonists in Prostate Cancer Randomized Controlled Trial
New England Journal of Medicine

Estradiol Patches Noninferior to LHRH Agonists in Prostate Cancer

A phase 3 trial shows transdermal estradiol maintains metastasis-free survival while reducing hot flashes in locally advanced disease.

April 23, 2026
Participation-Focused Training Improves Immediate Post-Stroke Executive Function in Randomized Trial Randomized Controlled Trial
Annals of Physical and Rehabilitation Medicine

Participation-Focused Training Improves Immediate Post-Stroke Executive Function in Randomized Trial

Strategy training shows short-term cognitive gains in stroke survivors, though benefits do not persist at three-month follow-up.

April 23, 2026
Immune-Guided Strategy Reduces CMV Disease in Kidney Transplant Recipients Non-Randomized Controlled Trial
Transplantation

Immune-Guided Strategy Reduces CMV Disease in Kidney Transplant Recipients

Early assessment of cell-mediated immunity allows for targeted prophylaxis, lowering symptomatic disease rates in seropositive patients.

April 23, 2026
Improved House Design Reduces Malaria and Respiratory Infections in Children Randomized Controlled Trial
Nature Medicine

Improved House Design Reduces Malaria and Respiratory Infections in Children

A cluster-randomized trial in rural Africa shows that Star Homes lower malaria incidence by 44% and improve linear growth in children.

April 23, 2026
Immersive Virtual Reality Improves Naming in Chronic Non-Fluent Aphasia Randomized Controlled Trial
Clinical Rehabilitation

Immersive Virtual Reality Improves Naming in Chronic Non-Fluent Aphasia

A randomized trial shows immersive therapy yields higher gains in oral motor function and patient enjoyment than conventional methods.

April 22, 2026
Memantine Reduces Premature Atrial Contractions and New-Onset Atrial Fibrillation Randomized Controlled Trial
Circulation

Memantine Reduces Premature Atrial Contractions and New-Onset Atrial Fibrillation

A phase 2 trial shows targeting cardiac N-methyl-D-aspartate receptors significantly lowers atrial ectopy and tachyarrhythmia burden.

April 22, 2026
Adding Tobramycin to Vancomycin Powder Does Not Reduce Tibial Fracture Infections Randomized Controlled Trial
JAMA

Adding Tobramycin to Vancomycin Powder Does Not Reduce Tibial Fracture Infections

A randomized trial of 1528 patients shows dual intrawound antibiotic powder offers no benefit over vancomycin alone in high-risk fractures.

April 22, 2026
Eccentric Cycling Matches Concentric Training for Post-COVID-19 Walking Recovery Randomized Controlled Trial
Annals of Physical and Rehabilitation Medicine

Eccentric Cycling Matches Concentric Training for Post-COVID-19 Walking Recovery

An 8-week trial shows eccentric cycling is safe and improves walking distance, though it offers no advantage over concentric exercise.

April 22, 2026
Mosunetuzumab and Polatuzumab Vedotin Show High Response in Refractory MCL Non-Randomized Controlled Trial
Blood Journal

Mosunetuzumab and Polatuzumab Vedotin Show High Response in Refractory MCL

A phase 2 trial reports a 78.6% complete response rate in patients with mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure.

April 22, 2026
Baseline Connectivity Predicts Anxiety Improvement in Prefrontal TMS Trial Randomized Controlled Trial
Neuropsychopharmacology

Baseline Connectivity Predicts Anxiety Improvement in Prefrontal TMS Trial

Pre-treatment neural architecture, rather than post-stimulation connectivity changes, correlates with clinical recovery in patients.

April 22, 2026
Seven-Day Low-Plastic Intervention Lowers Urinary Phthalates and Bisphenol A Randomized Controlled Trial
Nature Medicine

Seven-Day Low-Plastic Intervention Lowers Urinary Phthalates and Bisphenol A

A randomized trial shows that minimizing plastic contact in food and personal care reduces endocrine disruptors linked to metabolic risk.

April 22, 2026
Thrombectomy Increases Tissue Salvage in Distal Vessel Occlusion Stroke Randomized Controlled Trial
JAMA Neurology

Thrombectomy Increases Tissue Salvage in Distal Vessel Occlusion Stroke

A post hoc analysis of the DISTAL trial shows endovascular therapy preserves more at-risk brain tissue than medical management alone.

April 21, 2026
Cibisatamab and FAP-4-1BBL Show Activity in Refractory Colorectal Cancer Non-Randomized Controlled Trial
Nature Medicine

Cibisatamab and FAP-4-1BBL Show Activity in Refractory Colorectal Cancer

A phase 1b trial finds that combining a CEA-targeted bispecific antibody with localized 4-1BB co-stimulation induces objective responses.

April 21, 2026
Telehealth Integration Does Not Prevent Quality of Life Decline in Palliative Care Randomized Controlled Trial
Journal of Palliative Medicine

Telehealth Integration Does Not Prevent Quality of Life Decline in Palliative Care

A randomized trial of 182 patients found no significant differences in symptom burden or security between telehealth and standard care.

April 21, 2026
Large Language Models Reduce Radiology Reporting Time and Transcription Errors Non-Randomized Controlled Trial
European Radiology

Large Language Models Reduce Radiology Reporting Time and Transcription Errors

A multicenter study finds LLMs faster than conventional speech recognition but notes inconsistent efficiency and new error types.

April 21, 2026
Cilta-cel Induces Universal MRD Negativity in High-Risk Smoldering Multiple Myeloma Non-Randomized Controlled Trial
Nature Medicine

Cilta-cel Induces Universal MRD Negativity in High-Risk Smoldering Multiple Myeloma

A phase 2 trial shows 100% of patients achieved deep, sustained responses without prior induction therapy or disease progression.

April 21, 2026
Cerebral Oximetry Fails to Improve 2-Year Outcomes in Preterm Infants Randomized Controlled Trial
JAMA Pediatrics

Cerebral Oximetry Fails to Improve 2-Year Outcomes in Preterm Infants

A phase 3 trial of 1,601 infants shows no reduction in death or disability when using oximetry to guide early postnatal care.

April 21, 2026
Routine Dementia Screening Shows No Benefit or Harm for Family Members Randomized Controlled Trial
JAMA Internal Medicine

Routine Dementia Screening Shows No Benefit or Harm for Family Members

A randomized trial finds cognitive screening in primary care does not impact family quality of life, preparedness, or psychological distress.

April 21, 2026
Amoxicillin Equals Amoxicillin-Clavulanate for Acute Sinusitis Randomized Controlled Trial
JAMA

Amoxicillin Equals Amoxicillin-Clavulanate for Acute Sinusitis

A nationwide cohort study shows standard amoxicillin is as effective as amoxicillin-clavulanate but avoids higher risks of C. difficile.

April 21, 2026
Serious Games Reduce Geriatric Trauma Undertriage in Nontrauma Centers Randomized Controlled Trial
JAMA

Serious Games Reduce Geriatric Trauma Undertriage in Nontrauma Centers

A randomized trial of 800 emergency physicians shows digital simulation training improves adherence to triage guidelines for older adults.

April 21, 2026
Risk-Adapted Therapy Improves Survival in Pediatric Acute Myeloid Leukemia Non-Randomized Controlled Trial
Journal of Hematology & Oncology

Risk-Adapted Therapy Improves Survival in Pediatric Acute Myeloid Leukemia

Refined stratification using measurable residual disease and genetics increased 3-year overall survival to 83.9% in a large cohort.

April 21, 2026
Endovascular Therapy Eases Post-Thrombotic Syndrome but Increases Bleeding Randomized Controlled Trial
New England Journal of Medicine

Endovascular Therapy Eases Post-Thrombotic Syndrome but Increases Bleeding

Iliac-vein stenting with enhanced antithrombotics improves symptoms and quality of life at six months, despite a higher bleeding risk.

April 21, 2026
Routine Prednisolone Does Not Prevent Coronary Lesions in Kawasaki Disease Randomized Controlled Trial
New England Journal of Medicine

Routine Prednisolone Does Not Prevent Coronary Lesions in Kawasaki Disease

A large randomized trial shows that adding steroids to standard therapy does not protect the coronary arteries of unselected children.

April 21, 2026
Zongertinib Drives High Response in First-Line HER2-Mutant Lung Cancer Randomized Controlled Trial
New England Journal of Medicine

Zongertinib Drives High Response in First-Line HER2-Mutant Lung Cancer

The selective HER2 inhibitor achieved a 76% objective response rate and durable progression-free survival in treatment-naive patients.

April 21, 2026
Coping and Self-Efficacy Mediate Mood Improvements in Brain Tumor Caregivers Randomized Controlled Trial
Neuro-Oncology

Coping and Self-Efficacy Mediate Mood Improvements in Brain Tumor Caregivers

A secondary analysis of a randomized trial shows that a telehealth intervention reduces anxiety and depression by targeting specific psychological mec

April 21, 2026
Fecal Transplant Fails to Decolonize Resistant Bacteria in GI Disease Randomized Controlled Trial
JAMA Internal Medicine

Fecal Transplant Fails to Decolonize Resistant Bacteria in GI Disease

A randomized trial shows single-dose fecal microbiota transplant does not reduce multidrug-resistant organisms or resistance genes.

April 21, 2026